Source: Owler

Aerie Pharmaceuticals, Inc.: Aerie's revenue changed from $207.12M in Jun 2022 to $213.94M in Sep 2022

Aerie’s Trailing Twelve Months revenue changed from $207.12M in Jun 2022 to $213.94M in Sep 2022 increasing 3.3% in this time period.

Aerie Pharmaceuticals, Inc.'s Competitors | Aerie Pharmaceuticals, Inc.'s News | Aerie Pharmaceuticals, Inc.'s Financials

Followers on Owler

1,456

Est. Annual Revenue

$100-500M

Est. Employees

250-500

CEO

Raj Kannan

CEO Approval Rating

82/100

Aerie is a North Carolina-based pharmaceutical company that develops and commercializes novel therapies to treat open-angle glaucoma, ocular surface, and retinal diseases.